Rezeli, Melinda

Human iPSC-Derived Hippocampal Spheroids: An Innovative Tool for Stratifying Alzheimer Disease Patient-Specific Cellular Phenotypes and Developing Therapies

Pomeshchik, Y., Klementieva, O., Gil, J., Martinsson, I., Hansen, M. G., de Vries, T., Sancho-Balsells, A., Russ, K., Savchenko, E., Collin, A., et al. (2020) · Stem Cell Reports

Alzheimer's disease research and treatmentsPluripotent Stem Cells Research

Cited by 95

Limited Tumor Tissue Drug Penetration Contributes to Primary Resistance against Angiogenesis Inhibitors

Torok, S., Rezeli, M., Kelemen, O., Vegvari, A., Watanabe, K., Sugihara, Y., Tisza, A., Marton, T., Kovacs, I., Tovari, J., et al. (2017) · Theranostics

Angiogenesis and VEGF in CancerMass Spectrometry Techniques and Applications

Cited by 70

Clinical protein science in translational medicine targeting malignant melanoma

Gil, J., Betancourt, L. H., Pla, I., Sanchez, A., Appelqvist, R., Miliotis, T., Kuras, M., Oskolas, H., Kim, Y., Horvath, Z., et al. (2019) · Cell Biology and Toxicology

Melanoma and MAPK PathwaysAdvanced Proteomics Techniques and Applications

Cited by 45

Proteomic workflows for high-quality quantitative proteome and post-translational modification analysis of clinically relevant samples from formalin-fixed paraffin-embedded archives

Kuras, M., Woldmar, N., Kim, Y., Hefner, M., Malm, J., Moldvay, J., Döme, B., Fillinger, J., Pizzatti, L., Gil, J., et al. (2021) · Journal of Proteome Research

Advanced Proteomics Techniques and ApplicationsAdvanced Biosensing Techniques and Applications

Cited by 36

Development of an MRM assay panel with application to biobank samples from patients with myocardial infarction

Rezeli, M., Végvári, Á., Donnarumma, F., Gidlöf, O., Smith, J. G., Erlinge, D., & Marko-Varga, G. (2013) · Journal of Proteomics

Advanced Proteomics Techniques and ApplicationsMetabolomics and Mass Spectrometry Studies

Cited by 33

The Hidden Story of Heterogeneous B-raf V600E Mutation Quantitative Protein Expression in Metastatic Melanoma—Association with Clinical Outcome and Tumor Phenotypes

Betancourt, L. H., Szasz, A. M., Kuras, M., Rodriguez Murillo, J., Sugihara, Y., Pla, I., Horvath, Z., Pawłowski, K., Rezeli, M., Miharada, K., et al. (2019) · Cancers

Melanoma and MAPK PathwaysCutaneous Melanoma Detection and Management

Cited by 24

Mitochondrial and immune response dysregulation in melanoma recurrence

Szadai, L., Guedes, J. D. S., Woldmar, N., de Almeida, N. P., Jánosi, Á. J., Rajeh, A., Kovács, F., Kriston, A., Migh, E., Wan, G., et al. (2023) · Clinical and Translational Medicine

Cancer Immunotherapy and BiomarkersCutaneous Melanoma Detection and Management

Cited by 18

Moving towards high density clinical signature studies with a human proteome catalogue developing multiplexing mass spectrometry assay panels

Rezeli, M., Végvári, Á., Fehniger, T. E., Laurell, T., & Marko-Varga, G. (2011) · Journal of Clinical Bioinformatics

Advanced Proteomics Techniques and ApplicationsMass Spectrometry Techniques and Applications

Cited by 15